Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study.
Keisuke SuzukiShiho SuzukiTomohiko ShiinaYasuo HaruyamaHiroaki FujitaKei FunakoshiKoichi HirataPublished in: Journal of neurology (2023)
In our study, galcanezumab showed a significant effect in the first week after administration, and the RR at W1 could predict the RR at 3 months.
Keyphrases